Your browser doesn't support javascript.
loading
Evaluation of different platforms for the detection of anti-SARS coronavirus-2 antibodies, Thailand.
Lerdsamran, Hatairat; Mungaomklang, Anek; Iamsirithaworn, Sopon; Prasertsopon, Jarunee; Prasert, Kriengkrai; Intalapaporn, Poj; Siriyakorn, Nirada; Wiriyarat, Witthawat; Thinpan, Nattakan; Sawadpongpan, Suteema; Sirikhetkon, Somrak; Mongkalangoon, Noparat; Petto, Suwanna; Puthavathana, Pilaipan.
Afiliação
  • Lerdsamran H; Center for Research and Innovation, Faculty of Medical Technology, Mahidol University, Nakhon Pathom, 73170, Thailand.
  • Mungaomklang A; Institute for Urban Disease Control and Prevention, Department of Disease Control, Ministry of Public Health, Bangkok, 10220, Thailand.
  • Iamsirithaworn S; Department of Disease Control, Ministry of Public Health, Nonthaburi, 11000, Thailand.
  • Prasertsopon J; Center for Research and Innovation, Faculty of Medical Technology, Mahidol University, Nakhon Pathom, 73170, Thailand.
  • Prasert K; Department of Medical Services, Nakhon Phanom Provincial Hospital, Ministry of Public Health, Nakhon Phanom, 48000, Thailand.
  • Intalapaporn P; Division of Infectious Disease, Department of Medicine, Rajavithi Hospital, Ministry of Public Health, Bangkok, 10400, Thailand.
  • Siriyakorn N; Division of Infectious Disease, Department of Medicine, Rajavithi Hospital, Ministry of Public Health, Bangkok, 10400, Thailand.
  • Wiriyarat W; Faculty of Veterinary Science, Mahidol University, Nakhon Pathom, 73170, Thailand.
  • Thinpan N; Center for Research and Innovation, Faculty of Medical Technology, Mahidol University, Nakhon Pathom, 73170, Thailand.
  • Sawadpongpan S; Center for Research and Innovation, Faculty of Medical Technology, Mahidol University, Nakhon Pathom, 73170, Thailand.
  • Sirikhetkon S; Institute for Urban Disease Control and Prevention, Department of Disease Control, Ministry of Public Health, Bangkok, 10220, Thailand.
  • Mongkalangoon N; Department of Disease Control, Ministry of Public Health, Nonthaburi, 11000, Thailand.
  • Petto S; Institute for Urban Disease Control and Prevention, Department of Disease Control, Ministry of Public Health, Bangkok, 10220, Thailand.
  • Puthavathana P; Center for Research and Innovation, Faculty of Medical Technology, Mahidol University, Nakhon Pathom, 73170, Thailand. pilaipan.put@mahidol.edu.
BMC Infect Dis ; 21(1): 1213, 2021 Dec 06.
Article em En | MEDLINE | ID: mdl-34872510
ABSTRACT

BACKGROUND:

Antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) help determine previous infection in individuals, regardless of whether they are asymptomatic or symptomatic. The detection of antibodies serves several purposes, including supporting other assays for disease diagnosis, conducting seroepidemiological studies, and evaluating vaccines. Many platforms of immunological methods for anti-SARS-CoV-2 antibody detection and their performance require validation.

METHODS:

This study evaluated the test performance of three autoanalyzer-based assays (Architect IgG, Vitros IgG, and Vitros total Ig) and one manual ELISA (Wantai total Ig) against a microneutralization (microNT) assay on the detection of SARS-CoV-2 antibodies. Furthermore, an indirect immunofluorescence assay verified the discordant results between the microNT and commercial assays. The test sensitivity, specificity, positive predictive value, and negative predictive value were determined based on four groups of 1005 serum samples 102 COVID-19 prepandemic sera, 45 anti-SARS-CoV-2 positive sera, 366 sera of people at risk, and 492 sera of citizens returning from countries with a high prevalence of infection.

RESULTS:

The analyses as a whole showed that the performance of these commercial assays was comparable. Each group was also analysed separately to gain further insight into test performance. The Architect did not detect two positive sera of people at risk (prevalence of infection 0.55%). The other methods correctly identified these two positive sera but yielded varying false-positive results. The group of returning travellers with an infection rate of 28.3% (139 of 492) better differentiated the test performance of individual assays.

CONCLUSIONS:

High-throughput Architect and Vitros autoanalyzers appear appropriate for working on large sample sizes in countries that can afford the cost. The Wantai ELISA, while requiring more individual time and technical skill, may provide reliable results at a lower cost. The selection of assays will depend on the laboratory facilities and feasibility.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article